Department of Radiology, Shenzhen Children's Hospital, Shenzhen, China.
Development and Behavior Specialty, Shenzhen Children's Hospital, Shenzhen, China.
Brain Behav. 2022 Oct;12(10):e2758. doi: 10.1002/brb3.2758. Epub 2022 Sep 6.
Attention deficit/hyperactivity disorder (ADHD) is a hereditary neurodevelopmental disorder characterized by working memory (WM) deficits. The MnlI variant (rs3746544) of the synaptosomal-associated protein 25 (SNAP-25) gene is associated with ADHD. In this study, we investigated the role and underlying mechanism of SNAP-25 MnlI variant in cognitive impairment and brain functions in boys with ADHD.
We performed WM capacity tests using the fourth version of the Wechsler Intelligence Scale for Children (WISC-IV) and regional homogeneity (ReHo) analysis for the resting-state functional magnetic resonance imaging data of 56 boys with ADHD divided into two genotypic groups (TT homozygotes and G-allele carriers). Next, Spearman's rank correlation analysis between the obtained ReHo values and the WM index (WMI) calculated for each participant.
Compared with G-allele carrier group, there were higher ReHo values for the left medial prefrontal cortex (mPFC) and higher WM capacity in TT homozygote group. Contrary to TT homozygote group, the WM capacity was negatively correlated with the peak ReHo value for the left mPFC in G-allele carrier group.
These findings suggest that SNAP-25 MnlI variant may underlie cognitive and brain function impairments in boys with ADHD, thus suggesting its potential as a new target for ADHD treatment.
注意力缺陷多动障碍(ADHD)是一种遗传性神经发育障碍,其特征是工作记忆(WM)缺陷。突触相关蛋白 25(SNAP-25)基因的 MnlI 变体(rs3746544)与 ADHD 有关。在这项研究中,我们研究了 SNAP-25 MnlI 变体在 ADHD 男孩认知障碍和大脑功能中的作用及其潜在机制。
我们使用第四版韦氏儿童智力量表(WISC-IV)对 56 名 ADHD 男孩进行 WM 容量测试,并对其静息态功能磁共振成像数据进行区域同质性(ReHo)分析,将其分为两组基因型(TT 纯合子和 G 等位基因携带者)。然后,对每个参与者计算的 WM 指数(WMI)和获得的 ReHo 值进行 Spearman 秩相关分析。
与 G 等位基因携带者组相比,TT 纯合子组的左侧内侧前额叶皮质(mPFC)的 ReHo 值较高,WM 容量较大。与 TT 纯合子组相反,在 G 等位基因携带者组中,WM 容量与左侧 mPFC 的最大 ReHo 值呈负相关。
这些发现表明,SNAP-25 MnlI 变体可能是 ADHD 男孩认知和大脑功能障碍的基础,因此提示其可能成为 ADHD 治疗的新靶点。